Rohto Pharmaceutical Co.,Ltd.
4527.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥77 | ¥89 | ¥80 | ¥73 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥70 | ¥69 | ¥61 | ¥52 |
| Inventory | ¥62 | ¥47 | ¥41 | ¥34 |
| Other Curr. Assets | ¥9 | ¥10 | ¥9 | ¥6 |
| Total Curr. Assets | ¥218 | ¥215 | ¥190 | ¥164 |
| Property Plant & Equip (Net) | ¥90 | ¥69 | ¥66 | ¥63 |
| Goodwill | ¥47 | ¥2 | ¥3 | ¥3 |
| Intangibles | ¥9 | ¥7 | ¥7 | ¥6 |
| Long-Term Investments | ¥46 | ¥44 | ¥33 | ¥27 |
| Tax Assets | ¥4 | ¥4 | ¥5 | ¥5 |
| Other NC Assets | ¥7 | ¥6 | ¥6 | ¥5 |
| Total NC Assets | ¥204 | ¥131 | ¥119 | ¥110 |
| Other Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥422 | ¥346 | ¥310 | ¥275 |
| Liabilities | – | – | – | – |
| Payables | ¥22 | ¥21 | ¥19 | ¥16 |
| Short-Term Debt | ¥7 | ¥5 | ¥4 | ¥8 |
| Tax Payable | ¥0 | ¥5 | ¥6 | ¥3 |
| Deferred Revenue | ¥0 | ¥5 | ¥31 | ¥23 |
| Other Curr. Liab. | ¥55 | ¥25 | ¥2 | ¥5 |
| Total Curr. Liab. | ¥95 | ¥87 | ¥80 | ¥71 |
| LT Debt | ¥43 | ¥5 | ¥8 | ¥13 |
| Deferred Rev, NC | ¥0 | ¥1 | ¥3 | ¥3 |
| Deferred Tax Liab, NC | ¥2 | ¥2 | ¥1 | ¥1 |
| Other NC Liab. | ¥3 | ¥2 | ¥3 | ¥1 |
| Total NC Liab. | ¥56 | ¥12 | ¥14 | ¥19 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥1 | ¥1 | ¥1 |
| Total Liabilities | ¥150 | ¥99 | ¥95 | ¥91 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥7 | ¥7 | ¥7 | ¥7 |
| Retained Earnings | ¥228 | ¥209 | ¥184 | ¥162 |
| AOCI | ¥35 | ¥31 | ¥19 | ¥9 |
| Other Equity | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Equity | ¥260 | ¥246 | ¥210 | ¥178 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥11 | ¥1 | ¥6 | ¥6 |
| Total Liab. & Tot. Equity | ¥422 | ¥346 | ¥310 | ¥275 |
| Net Debt | -¥27 | -¥79 | -¥68 | -¥51 |